DLCO declined earliest, falling measurably about 10 years before the defined onset. By five years before onset, DLCO had ...
MedPage Today on MSN
Inhaled vasodilator slows lung function decline in idiopathic pulmonary fibrosis
Clinical worsening also occurred less frequently with treprostinil ...
Credit: Getty Images. The first step in diagnosing idiopathic pulmonary fibrosis is ruling out other known causes of interstitial lung disease. Making an accurate diagnosis of IPF is critical because ...
Baseimmune unveils a new multi-pathway immunotherapy strategy, applying its computational protein design platform to develop next-generation therapies for fibrosis. Fibrosis is driven by complex and ...
PPF is identified by decline in lung function, worsening symptoms, and increased fibrosis on imaging, with variable criteria across studies. Risk factors for PPF include older age, male sex, smoking, ...
Type 2 diabetes and prediabetes can both significantly impact pulmonary health, highlighting the need for early detection and intervention. A new paper has highlighted the significant impact of type 2 ...
St. Luke’s University Health Network has been designated as a Care Center within the Pulmonary Fibrosis Foundation’s nationally recognized Care Center Network, expanding access to specialized care ...
Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...
The COVID-19 pandemic engulfed the U.S. five years ago this month, leaving not only lingering mental health effects but also long-term physical symptoms. One of those included a condition known as ...
A common over-the-counter ingredient in many cough syrups may have a greater purpose for people suffering from lung fibrosis that is related to any number of serious health conditions. A new study has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results